Multimorbidity and polypharmacy: a risk factor for older patients

Multimorbidity and polypharmacy: a risk factor for older patients

Authors

  • Domenico Cucinotta Aging section Editor, Acta Biomedica

Keywords:

Multimorbidity, polypharmacy, older patients

Abstract

Invited commentary on Letter: Acta Biomed 2022; Vol. 93, N. 2: e2022136 DOI 10.23750/abm.v93i2.12855

https://mattioli1885journals.com/index.php/actabiomedica/article/view/12855

 

References

Linea Guida Intersocietaria per la gestione della comorbilità e della multipatologia .ISTITUTO SUPERIORE DI SANITÀ Italy, , 4 Giugno 2021

Polypharmacy Guidance Realistic Prescribing NHS Scotland 2018. https://www.therapeutics.scot.nhs.uk 2018/04

Budnitz DS, et el Emergency hospitalizations for adverse drug events in older Americans. N. E. J. M. 2011;365(21):2002-12

htpp://DEPRESCRIBING.ORG Optimizing medication use

Rochon P.A. et al, Polypharmacy, inappropriate prescribing, and deprescribing in older people: through a sex and gender lens Lancet Healthy Longev 2021; 2: e290–300

International Association of Gerontology and Geriatrics European Region, Ex Com.2003

Downloads

Published

11-05-2022

Issue

Section

INVITED COMMENTARY

How to Cite

1.
Cucinotta D. Multimorbidity and polypharmacy: a risk factor for older patients. Acta Biomed [Internet]. 2022 May 11 [cited 2024 Jul. 20];93(2):e2022137. Available from: https://www.mattioli1885journals.com/index.php/actabiomedica/article/view/12911